معرفی
Rahul Roy is a Researcher in the Department of Medical Oncology and Hematology at Yale University’s Yale School of Medicine. His work focuses on molecular mechanisms underlying hematologic malignancies, transcriptional regulation defects, and translational applications in cancer therapy. Key research areas include splicing factor mutations in myelodysplastic syndromes (MDS), chromatin organization dynamics, DNA repair pathways, and microbiome-driven disease mechanisms.
Research Interests
- Investigating SF3B1 mutations' impact on chromatin architecture and transcription elongation
- Developing biomarkers for Mucorales infections using nanotechnology
- Exploring tight junction proteins as novel therapeutic targets in cancer and inflammation
- Characterizing gut microbiome signatures in severe liver diseases and colorectal cancer
His recent studies highlight transcriptional defects in splicing factor-mutant MDS and identify potential therapeutic targets via chromatin landscape alterations. Work on nanotextured drug-delivery systems demonstrates innovative approaches to osteogenesis and anti-cancer applications. Collaborative projects span molecular diagnostics, epigenetic regulation, and microbiome-driven pathology.
No scientific awards have been listed for this researcher.
Grants & Advising
No information available on current grants or advisees.
No active lab teams or collaborative groups are explicitly mentioned in the provided profile.
